Task: Answer the multiple choice question.
Question: Which drug exhibits a -24.964% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) CC(=O)N(C)c1ccc(NC(=O)N2CCOCC2)cc1
b.) Cc1ccc(-n2c(N)c(C(=O)N3CCOCC3)sc2=S)cc1
Answer: b. Cc1ccc(-n2c(N)c(C(=O)N3CCOCC3)sc2=S)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(-n2c(N)c(C(=O)N3CCOCC3)sc2=S)cc1
Cc1ccc(-n2c(N)c(C(=O)N3CCOCC3)sc2=S)cc1
[4-amino-3-(4-methylphenyl)-2-sulfanylidene-1,3-thiazol-5-yl]-morpholin-4-ylmethanone